Description of the medicine: Vikasol (Vicasolum)

VICASOL (Vicasolum) 2, 3-Dihydro-2-methyl-1, 4-naphthoquinone-2-sulphonate.

White or white with a yellowish tint crystal powder without the smell. It is easily soluble in water, it is difficult in alcohol.

Vikasol is a synthetic analogue of vitamin K. It is considered as vitamin K 3.

Unlike natural preparations of vitamin K (phytomenadion, etc.), vikasol is a water-soluble compound and can be used not only inward, but also parenterally.

Vikasol has been proposed for use in a number of pathological conditions, accompanied by hypoprothrombinemia and bleeding, including jaundice in case of delayed bile flow, intractable hepatitis, parenchymal and capillary bleeding, after injury or surgery, bleeding in peptic ulcer and duodenal ulcer, Radiation sickness, hemorrhoidal and long-nasal bleeding; Prophylactically - in pregnant women during the last month of pregnancy to prevent the bleeding of newborns; In the presence of hemorrhagic phenomena in premature infants; With uterine juvenile and pre-climactericcrootations; Spontaneous bleeding; Preparation for surgical operations, and also in the postoperative period, if there is a risk of bleeding, with pulmonary bleeding for pulmonary tuberculosis, septic diseases accompanied by hemorrhagic phenomena. There are indications that when using vikasol (and other preparations of vitamin K), there may be inhibition of platelet aggregation, which should take into account the purpose of these drugs.

They are also used for hypoprothrombinemia and bleeding associated with an overdose of neodicumarin, phenylin and other anti-coagulants (vitamin K antagonists).

The drug is administered orally in the form of a powder, in tablets or in solution, as well as intramuscularly. The daily dose of vikasol for adults with oral administration is 0.015-0.03 g, for intramuscular injection 0.01-0.015 g.

Children under the age of 1 year are prescribed 0,002 to 0,005 grams, to 2 years to 0,006 grams, 3 to 4 years to 0,008 grams, 5 to 9 years to 0,01 grams, and 10 to 14 years to 0,015 g. For newborns, the dose is not Should exceed 0. 004 g (inside).

Assign for 3 to 4 consecutive days, after which they take a break for 4 days. After a break, the administration of vicasol is repeated for 3 to 4 days. The daily dose can be divided into 2 to 3 doses. Before operations accompanied by severe parenchymal hemorrhages, it is recommended to start taking Vikasol 2 to 3 days before the operation.

Higher doses for adults inside: single 0.03 g, daily 0.06 g; Intramuscularly: single 0,015 g, daily 0,03 g.

Vicasol is contraindicated in cases of increased coagulability of thromboembolism.

Form release: powder; Tablets of 0.015 g; 1% solution vampula 1 ml each.

Storage: List B. In a well-ukuporennoy packaging, protecting the action of light.